Does parenteral PPI therapy decrease rebleeding in peptic ulcer disease (PUD)?

Updated: Apr 26, 2021
  • Author: BS Anand, MD; Chief Editor: Philip O Katz, MD, FACP, FACG  more...
  • Print

A Canadian database (RUGBE) indicated some benefit from parenteral PPI in decreasing rebleed rates. [49] No randomized, controlled trial has provided evidence to support the use of parenteral PPI in this setting, but giving oral PPI both before and after EHT for persons with peptic ulcers with signs of recent hemorrhage can be justified on the grounds of cost-effectiveness. [25]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!